Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
How A/B Dynamics Transformed Its Workspace: A Conversation with CEO Tim Rogers
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Interview with Tim Rogers CEO
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
investment thesis and current investment climate|Michael A. Rotgin,Partner and Chief Operating Officer,Shelter Capital
00:10:00
Antony Beckmand Explores Ertelien’s Historic Drilling Program in Latest Kuniko Interview | Antony Beckmand , CEO, Kuniko Limited.
00:10:00
Orvana Minerals Highlights Operational Turnaround and Growth Prospects in Spain, Bolivia, and Argentina
00:10:00
Spotlight on Fernando: Mechanical Engineer at JL Richards Discusses Global Mining Projects
00:10:00
Shahar Bar, SVP of Video Products & Corporate Development at Harmonic Inc., discusses competition in the media industry.
00:10:00
Jesse Fink: A Journey of Impact and Philanthropy in Action at MissionPoint Capital Partners
00:10:00
Voyager Life PLC's Rapid Growth and Expansion in CBD Market | Nick Tulloch, CEO, Voyager Life PLC.
00:10:00
On Thursday, July 22, Paul Boudre, CEO of Soitec, focused on the semiconductor market and Soitec's projects to develop its initiatives.|Paul Boudre, CEO of Soitec
00:10:00
help technical founders turn machine learning models|Mark Gorenberg,Managing Director,Zetta Venture Partners
00:10:00
Deidre Campbell, Global Chair, Financial Services Sector, Edelman
00:10:00
David Elizaga: CFO of eDreams ODIGEO and Financial Strategist | David Elizaga, CFO, eDreams ODIGEO SA.
00:10:00
Cosmin Gita Discusses Romania's Nuclear Energy Strategy and Future Plans | Cosmin Ghita, CEO, Nuclearelectrica SA.